Octagon Research Solutions’,Chairman and Chief Executive Officer Jim Walker was named as a “Best Chairman” finalist in the 2008 American Business Awards.
WAYNE, PA, May, 30, 2008- Octagon Research Solutions, Inc., a pioneer and leading provider of breakthrough software and services to the life sciences industry, today announced that Jim Walker, chairman and chief executive officer, was named as a finalist in the category of “Best Chairman” in the 2008 American Business Awards. The American Business Awards are the only national, all-encompassing awards program honoring great performances in business.
Stevie® Award winners will be announced during the annual gala on Thursday, June 12 at the Marriott Marquis Hotel in New York City. More than 600 executives from across the U.S. are expected to attend. The ceremonies will be broadcast on radio nationwide by the Business TalkRadio Network and hosted by Liz Claman of FOX Business Network.
More than 2600 entries from companies of all sizes and in virtually every industry were submitted for consideration in more than 40 categories, including Best Overall Company, Best Executive, Best New Product or Service, Best Corporate Responsibility Program, and new categories including Best Management Team and Best Corporate Environmental Responsibility Program. Jim Walker will be competing in the Management category for Best Chairman.
Members of the Awards’ Board of Distinguished Judges & Advisors and their staffs will select Stevie Award winners from among Finalists in final judging during the week of May 19. Finalists are chosen by business professionals nationwide during preliminary judging in April through early May.
“ABA entries grew more than 30% this year, so being named a Finalist is more of an accomplishment than ever before,” said Michael Gallagher, founder and president of the Stevie Awards. “It means that independent business executives have agreed that the nominee is worthy of national recognition. We congratulate all of the finalists on their achievement and wish them well in the competition.”
Walker noted, “It is an honored to be a finalist among such accomplished individuals. When Octagon was founded in 1999, our vision was to transform the industry’s view of clinical R&D. That vision has been realized through the dedication and talent of my senior staff and the ability of each Octagon employee to embrace that vision and bring it to reality. I am grateful for the recognition this nomination brings.”
Details about The American Business Awards and the list of Finalists in all categories are available at www.stevieawards.com/aba.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.